Header Logo

Connection

NORMAN SUSSMAN to Liver Transplantation

Back to Details
This is a "connection" page, showing publications NORMAN SUSSMAN has written about Liver Transplantation.
NORMAN SUSSMAN
Connection Strength
2.015
Liver Transplantation
  1. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018 05; 24(5):711.
    View in: PubMed
    Score: 0.332
  2. Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation. Liver Transpl. 2016 Mar; 22(3):279-80.
    View in: PubMed
    Score: 0.287
  3. Long-term follow-up of portopulmonary hypertension patients after liver transplantation. Liver Transpl. 2014 Jun; 20(6):724-7.
    View in: PubMed
    Score: 0.255
  4. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant. 2006 Sep; 6(9):2177-82.
    View in: PubMed
    Score: 0.147
  5. Indeterminate etiology of acute liver failure in North America: Less common, still grave prognosis. Clin Transplant. 2023 12; 37(12):e15128.
    View in: PubMed
    Score: 0.121
  6. Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America. Liver Transpl. 2023 06 01; 29(6):570-580.
    View in: PubMed
    Score: 0.117
  7. Drug-Induced Liver Injury in the Setting of Analgesic Use. Clin Liver Dis. 2020 02; 24(1):121-129.
    View in: PubMed
    Score: 0.093
  8. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.087
  9. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.085
  10. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.081
  11. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 07; 101(7):1609-1615.
    View in: PubMed
    Score: 0.079
  12. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.078
  13. Portopulmonary hypertension: an update. Liver Transpl. 2012 Aug; 18(8):881-91.
    View in: PubMed
    Score: 0.056
  14. Pulmonary complications in cirrhosis. Curr Opin Organ Transplant. 2011 Jun; 16(3):281-8.
    View in: PubMed
    Score: 0.052
  15. Hepatic assist devices: will they ever be successful? Curr Gastroenterol Rep. 2009 Feb; 11(1):64-8.
    View in: PubMed
    Score: 0.044
  16. Larsucosterol for the Treatment of Alcohol-Associated Hepatitis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400243.
    View in: PubMed
    Score: 0.033
  17. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996 Dec; 24(6):1446-51.
    View in: PubMed
    Score: 0.019
  18. Treatment of hepatic failure--1996: current concepts and progress toward liver dialysis. Am J Kidney Dis. 1996 May; 27(5):605-21.
    View in: PubMed
    Score: 0.018
  19. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. ASAIO J. 1994 Jan-Mar; 40(1):83-5.
    View in: PubMed
    Score: 0.015
  20. Extracorporeal liver assist in the treatment of fulminant hepatic failure. Blood Purif. 1993; 11(3):170-4.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.